Stockscreener 앱 받기
23.86
1.28%
-0.31
전일 마감가:
$24.17
열려 있는:
$23.9
하루 거래량:
1.58M
Relative Volume:
0.63
시가총액:
$2.98B
수익:
-
순이익/손실:
$-238.77M
주가수익비율:
-0.89
EPS:
-26.808
순현금흐름:
$-216.62M
1주 성능:
+21.98%
1개월 성능:
+109.30%
6개월 성능:
+593.60%
1년 성능:
+206.29%
1일 변동 폭
$23.36
$24.54
1주일 범위
$19.55
$25.19
52주 변동 폭
$2.7601
$25.19
Alumis Inc Stock (ALMS) Company Profile
명칭
Alumis Inc
전화
650-231-6625
주소
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
ALMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALMS
Alumis Inc
|
23.86 | 3.01B | 0 | -238.77M | -216.62M | -26.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-25 | 개시 | Wells Fargo | Overweight |
| 2025-06-10 | 재개 | Guggenheim | Buy |
| 2025-01-30 | 개시 | Oppenheimer | Outperform |
| 2024-10-31 | 개시 | Robert W. Baird | Outperform |
| 2024-10-17 | 개시 | H.C. Wainwright | Buy |
| 2024-07-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-23 | 개시 | Guggenheim | Buy |
| 2024-07-23 | 개시 | Leerink Partners | Outperform |
| 2024-07-23 | 개시 | Morgan Stanley | Overweight |
모두보기
Alumis Inc 주식(ALMS)의 최신 뉴스
Staar Surgical, Alumis, and more stocks see action from activist investors - MSN
HC Wainwright & Co. hikes Alumis Inc. (ALMS)’s price target to $40 from $20, reiterates buy rating - MSN
HC Wainwright & Co. Hikes Alumis Inc. (ALMS)’s Price Target To $40 From $20, Reiterates Buy Rating - Insider Monkey
Alumis (ALMS) Is Up 35.8% After Psoriasis Data And $300M Raise Has The Bull Case Changed? - simplywall.st
Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib - AOL.com
Alumis (ALMS) price target increased by 79.14% to 36.28 - MSN
Alumis (ALMS) stock jumps as insider filings show $17 buys — what investors are watching next - TechStock²
Why Alumis Inc. Stock Is Surging Right Now - TipRanks
Alumis (NASDAQ:ALMS) Stock Price Up 6.6% Following Insider Buying Activity - MarketBeat
Alumis' Meteoric Rise To $20 From $5 In Just 60 Days On Plaque Psoriasis Trial Results - Nasdaq
Alumis (ALMS) Price Target Increased by 79.14% to 36.28 - Nasdaq
Assessing Alumis (ALMS) Valuation After Positive Phase 3 Psoriasis Data And Follow On Equity Offering - simplywall.st
Insider Makes Bold Multimillion-Dollar Bet on Alumis Inc. - TipRanks
Insider Buying: Alumis (NASDAQ:ALMS) Director Purchases 588,235 Shares of Stock - MarketBeat
Aug Sectors: Will Alumis Inc stock benefit from automation2025 Performance Recap & Low Drawdown Momentum Trade Ideas - moha.gov.vn
Akkaraju of Alumis buys shares worth $9.9 million By Investing.com - Investing.com Nigeria
Akkaraju of Alumis buys shares worth $9.9 million - Investing.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, Warren Buffett, Balyasny Asset Management, Schonfeld Strategic Advisors, Renaissance Technologies, Anson Investments, Limoneira Co (LMNR), Alumis Inc (ALMS), and More - Insider Monkey
Alumis (NASDAQ:ALMS) Reaches New 1-Year High on Insider Buying Activity - MarketBeat
Alumis Inc stock hits all-time high at 22.33 USD - Investing.com India
Why Alumis Inc. Stock Is Quietly Surging Higher - TipRanks
Support Test: Is Alumis Inc stock a buy on dipsMarket Activity Summary & Weekly Top Gainers Alerts - Bộ Nội Vụ
Alumis Inc. Stock (ALMS) Opinions on Phase 3 Trial Results - Quiver Quantitative
Latham & Watkins Advises on Alumis’ Upsized US$345 Million Public Offering of Common Stock - Legal Desire Media and Insights
Insider Buying: Alumis (NASDAQ:ALMS) Major Shareholder Buys 411,764 Shares of Stock - MarketBeat
Alumis Insider Bought Shares Worth $6,999,988, According to a Recent SEC Filing - marketscreener.com
Alumis (NASDAQ:ALMS) Major Shareholder Buys $6,999,988.00 in Stock - MarketBeat
Foresite Labs buys Alumis (ALMS) shares worth $7 million - Investing.com
Foresite Labs buys Alumis (ALMS) shares worth $7 million By Investing.com - Investing.com Canada
Alumis (ALMS) director Tananbaum buys shares worth $6.99m By Investing.com - Investing.com South Africa
Foresite Capital buys Alumis (ALMS) shares worth $7m By Investing.com - Investing.com South Africa
Foresite Capital buys Alumis (ALMS) shares worth $7m - Investing.com
Aug Decliners: Is Alumis Inc gaining market share2025 Price Momentum & Low Drawdown Trading Strategies - baoquankhu1.vn
Investment Review: Is Alumis Inc gaining market shareShort Setup & Verified Momentum Stock Watchlist - baoquankhu1.vn
Alumis Stock Skyrockets Amid Significant Drug Trial Success - StocksToTrade
Alumis Stock Soars After Phase 3 Trial Success - timothysykes.com
Alumis stock hits record high as Wall Street cheers phase 3 psoriasis 'win' — analysts see best-in-class potential - MSN
Alumis Inc. (NASDAQ:ALMS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Alumis announces phase 3 trial of envudeucitinib met all primary endpoints - MSN
Alumis raises $345.1 million in upsized public offering By Investing.com - Investing.com India
Alumis raises $345.1 million in upsized public offering - Investing.com
Alumis Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Alumis Inc. Announces Closing of $345.1 Million Upsized Public Offering of Common Stock - Quiver Quantitative
ALMSAlumis Inc Latest Stock News & Market Updates - Stock Titan
Can Alumis Inc. stock hit record highs againPerformance Line Overview & updated model highlights and notes - ulpravda.ru
Alumis launches sizable common stock public offering - TipRanks
Can Alumis Inc. stock maintain growth trajectoryJuly 2025 Movers & Verified Momentum Stock Watchlist - ulpravda.ru
What's Going On With Alumis Stock Thursday? - Sahm
Alumis (ALMS) Is Up 83.6% After Phase 3 Psoriasis Win And NDA PlanHas The Bull Case Changed? - Sahm
Alumis Inc (ALMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Alumis Inc 주식 (ALMS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Foresite Labs, LLC | 10% Owner |
Jan 08 '26 |
Buy |
17.00 |
411,764 |
6,999,988 |
5,702,536 |
| Foresite Capital Management VI | 10% Owner |
Jan 08 '26 |
Buy |
17.00 |
411,764 |
6,999,988 |
5,702,536 |
| Tananbaum James B. | Director |
Jan 08 '26 |
Buy |
17.00 |
411,764 |
6,999,988 |
5,702,536 |
| AKKARAJU SRINIVAS | Director |
Dec 05 '25 |
Buy |
9.84 |
186,377 |
1,833,760 |
1,265,253 |
| AKKARAJU SRINIVAS | Director |
Dec 03 '25 |
Buy |
7.75 |
100,000 |
775,000 |
1,012,849 |
| AKKARAJU SRINIVAS | Director |
Dec 02 '25 |
Buy |
7.55 |
96,000 |
724,800 |
912,849 |
| AKKARAJU SRINIVAS | Director |
Dec 04 '25 |
Buy |
8.18 |
66,027 |
540,101 |
1,078,876 |
| AKKARAJU SRINIVAS | Director |
Dec 01 '25 |
Buy |
7.46 |
86,350 |
644,171 |
816,849 |
| AKKARAJU SRINIVAS | Director |
Nov 26 '25 |
Buy |
7.64 |
48,537 |
370,823 |
691,797 |
| AKKARAJU SRINIVAS | Director |
Nov 28 '25 |
Buy |
7.64 |
38,702 |
295,683 |
730,499 |
4.73%
0.92%
자본화:
|
볼륨(24시간):